Regulation of interleukin‐1β–induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin‐3‐gallate in rheumatoid arthritis synovial fibroblasts

Abstract

These results suggest that EGCG may be of potential therapeutic value in inhibiting joint destruction in RA.